KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity

Annual Review of Immunology

Volumn 20, Issue , 2002, Pages 217-251

  Vilches, Carlos ^a   Parham, Peter ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Evolution; Gene diversity; MHC; NK cells; Polymorphism

Indexed keywords

GENE PRODUCT; IMMUNOGLOBULIN RECEPTOR; LECTIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN KIR; UNCLASSIFIED DRUG;

ALLELISM; ANTIGEN RECOGNITION; BIODIVERSITY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HLA SYSTEM; HUMAN; IMMUNITY; IMMUNOMODULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR EVOLUTION; NATURAL KILLER CELL; NONHUMAN; PHYLOGENY; PRIMATE; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SPECIES DIFFERENCE; STRUCTURE ANALYSIS; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; EVOLUTION; GENE EXPRESSION; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PHYLOGENY; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; SEQUENCE HOMOLOGY, AMINO ACID; VARIATION (GENETICS);

EID: 0036215134     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.20.092501.134942     Document Type: Review

References (172)

1. Biology of natural killer cells
2. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
3. Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48
4. Turning on natural killer cells
5. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
6. 2B4-mediated activation of human natural killer cells
7. On guard-activating NK cell receptors
8. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
9. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
10. ULBP1, 2, 3: Novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells
11. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
12. How to recognize a foreign submarine
13. Human pathogen subversion of antigen presentation
14. Cytomegalovirus evasion of natural killer cell responses
15. Viral subversion of the immune system
16. The HLA crossroad in tumor immunology
17. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
18. HLA-E binds to natural killer cell receptors CD94/NKG2A B and C
19. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
20. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
21. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells
22. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules
23. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
24. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences
25. Killer cell receptors: Keeping pace with MHC class I evolution
26. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b)
27. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors
28. The Ly-49 family: Genes, proteins and recognition of class I MHC
29. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors
30. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40
31. The selective down-regulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
32. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules
33. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11
34. A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells
35. Human cytomegalovirus and natural killer-mediated surveillance of HLA class I expression: A paradigm of host-pathogen adaptation
36. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically
37. Immunoreceptor DAP12 beating a tyrosine-based activation motif is involved in activating NK cells
38. The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster
39. Genes encoding human killer-cell Ig-like receptors with D1 and D2 extracellular domains all contain untranslated pseudoexons encoding a third Ig-like domain
40. Genomic organization of a human killer cell inhibitory receptor gene
41. Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103
42. Gene structure and promoter variation of expressed and non-expressed variants of the KIR2DL5 gene
43. Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR), 1998
44. LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase
45. Induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD 158d) in resting NK cells
46. Isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex
47. KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains
48. Plasticity in the organization and sequences of human KIR/ILT gene families
49. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158)
50. Short KIR haplotypes in pygmy chimpanzee (Bonobo) resemble the conserved framework of diverse human KIR haplotypes
51. Divergent and convergent evolution of NK-cell receptors
52. Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4
53. Human diversity in killer cell inhibitory receptor genes
54. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination
55. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires
56. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism
57. Discovery of two novel variants of KIR2DS5 reveals this gene to be a common component of human KIR 'B' haplotypes
58. Killer-cell immunoglobulin-like receptor gene haplotypes contain between zero and two KIR2DL5 loci
59. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors
60. Evidence for recombination as a mechanism for KIR diversification
61. Identification of seventeen novel KIR variants: Fourteen of them from two non-Caucasian donors
62. Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual
63. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans
64. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual
65. Diversity of the p70 killer cell inhibitory receptor (KIR3DL) family members in a single individual
66. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2
67. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex
68. Diversity of the killer cell Ig-like receptors of rhesus monkeys
69. Primate Mhc-E and -G alleles
70. P49, a putative HLA-G1 specific inhibitory NK receptor belonging to the immunoglobulin superfamily
71. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells
72. NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains
73. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily
74. Detection of KIR2DL4 alleles by sequencing and SSCP reveals a common allele with a shortened cytoplasmic tail
75. Evidence for an HLA-C-like locus in the orangutan Pongo pygmaeus
76. Major histocompatibility complex class I genes in primates: Co-evolution with pathogens
77. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA
78. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction
79. The neighbour-joining method: A new method for reconstructing phylogenetic trees
80. Confidence limits on phylogenies: An approach using the bootstrap
81. Allelic diversity at the primate Mhc-G locus: Exon 3 bears stop codons in all Cercopithecinae sequences
82. Identification of the rhesus monkey HLA-G ortholog. Mamu-G is a pseudogene
83. Identification of a novel MHC class I gene. Mamu-AG, expressed in the placenta of a primate with an inactivated G locus
84. Alternatively spliced forms of human killer inhibitory receptors
85. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions
86. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes
87. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors
88. Killer cell inhibitory receptors: Diversity, specificity, and function
89. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer
90. Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells
91. Definition of polymorphic residues on killer Ig-like receptor proteins which contribute to the HLA-C binding site
92. Human natural killer cell inhibitory receptors bind to HLA class I molecules
93. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules
94. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule
95. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors
96. A disulfide-linked natural killer cell receptor dimer has higher affinity for HLA-C than wild-type monomer
97. Cobalt-mediated dimerization of the human natural killer cell inhibitory receptor
98. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors
99. Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties
100. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand
101. Molecular analyses of the interactions between human NK receptors and their HLA ligands
102. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors
103. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I
104. Human NK cells: Their ligands, receptors and functions
105. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes
106. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition
107. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules
108. The binding site of NK receptors on HLA-C molecules
109. The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C
110. IMGT/HLA database - A sequence database for the human major histocompatibility complex
111. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity
112. Self and viral peptides can initiate lysis by autologous natural killer cells
113. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis
114. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705
115. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells
116. Natural killer cell-mediated lysis of autologous cells modified by gene therapy
117. Molecular structure of human histocompatibility antigens: The HLA-C series
118. The human natural killer cell immune synapse
119. The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteins
120. The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells
121. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors
122. Enhancement of class II-restricted T cell responses by co-stimulatory NK receptors for class I MHC proteins
123. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex
124. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4
125. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation
126. NKB1: A natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules
127. The NKB1 and HP-3EA NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules
128. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor
129. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes
130. Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: Their role in the definition of different groups of alloreactive NK cell clones
131. The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer
132. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix
133. Nomenclature for factors of the HLA system, 1994
134. Nomenclature for factors of the HLA system, 1996
135. Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: Requirement for all three p70 immunoglobulin domains
136. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80
137. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones
138. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor
139. + NK cells by HLA-B7 variants and target cells
140. A human killer inhibitory receptor specific for HLA-A
141. Class I-induced resistance to natural killing: Identification of nonpermissive residues in HLA-A2
142. Specificity of HLA class I antigen recognition by human NK clones: Evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type
143. Recognition of trophoblast HLA class I molecules by decidual NK cell receptors - A review
144. Surface expression of HLA-C antigen by human extravillous trophoblast
145. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells
146. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells
147. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells
148. Multiple receptors for HLA-G on human natural killer cells
149. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells
150. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor
151. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition
152. + natural killer cells. Role in cell activation and regulation of cytolytic function
153. Regulation of the natural killer cell receptor repertoire
154. Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements
155. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations
156. The repertoire of killer-cell Ig-like receptor and CD94:NKG2A receptors in T cells: Clones sharing identical alpha-beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns
157. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL
158. + T cells
159. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes
160. Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1
161. Conserved organization of the ILT/LIR gene family within the polymorphic human leukocyte receptor complex
162. HLA-G1 protein expression is not essential for fetal survival
163. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis
164. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity
165. +CD28null T cells clonally expanded in rheumatoid arthritis
166. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis
167. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts
168. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming
169. Vital involvement of a natural killer cell activation receptor in resistance to viral infection
170. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily
171. Human cytomegalovirus. MHC class I and inhibitory signalling receptors: More questions than answers
172. Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T-cell responses